Novel antibody reduces tumor growth in treatment-resistant breast and ovarian cancers
Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
News Medical on MSN22d
Vimseltinib Approved by FDA for Tenosynovial Giant Cell Tumor
The investigators reported that 67% of patients receiving vimseltinib had measurably reduced tumor volume, compared with none in the placebo group. Additionally, patients in the trial who received ...
Nature1mon
Human Tumor Atlas Network
The Human Tumor Atlas Network leverages scientific collaboration to integrate samples, analytical modalities and tools into detailed atlases of tumor evolution. Expanding our spatial understanding ...
mskcc.org24d
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumor (TGCT)
The investigators reported that 67% of patients receiving vimseltinib had measurably reduced tumor volume, compared with none in the placebo group. Additionally, patients in the trial who received ...